Understanding the role of antibiotic-associated adverse events in influencing antibiotic decision-making
© The Author(s) 2024..
Objective: To (1) understand the role of antibiotic-associated adverse events (ABX-AEs) on antibiotic decision-making, (2) understand clinician preferences for ABX-AE feedback, and (3) identify ABX-AEs of greatest clinical concern.
Design: Focus groups.
Setting: Academic medical center.
Participants: Medical and surgical house staff, attending physicians, and advanced practice practitioners.
Methods: Focus groups were conducted from May 2022 to December 2022. Participants discussed the role of ABX-AEs in antibiotic decision-making and feedback preferences and evaluated the prespecified categorization of ABX-AEs based on degree of clinical concern. Thematic analysis was conducted using inductive coding.
Results: Four focus groups were conducted (n = 15). Six themes were identified. (1) ABX-AE risks during initial prescribing influence the antibiotic prescribed rather than the decision of whether to prescribe. (2) The occurrence of an ABX-AE leads to reassessment of the clinical indication for antibiotic therapy. (3) The impact of an ABX-AE on other management decisions is as important as the direct harm of the ABX-AE. (4) ABX-AEs may be overlooked because of limited feedback regarding the occurrence of ABX-AEs. (5) Clinicians are receptive to feedback regarding ABX-AEs but are concerned about it being punitive. (6) Feedback must be curated to prevent clinicians from being overwhelmed with data. Clinicians generally agreed with the prespecified categorizations of ABX-AEs by degree of clinical concern.
Conclusions: The themes identified and assessment of ABX-AEs of greatest clinical concern may inform antibiotic stewardship initiatives that incorporate reporting of ABX-AEs as a strategy to reduce unnecessary antibiotic use.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:4 |
|---|---|
| Enthalten in: |
Antimicrobial stewardship & healthcare epidemiology : ASHE - 4(2024), 1 vom: 01., Seite e13 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Cherian, Jerald P [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 29.02.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1017/ash.2024.2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369050045 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369050045 | ||
| 003 | DE-627 | ||
| 005 | 20240229235458.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240229s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1017/ash.2024.2 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1311.xml |
| 035 | |a (DE-627)NLM369050045 | ||
| 035 | |a (NLM)38415083 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Cherian, Jerald P |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Understanding the role of antibiotic-associated adverse events in influencing antibiotic decision-making |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 29.02.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © The Author(s) 2024. | ||
| 520 | |a Objective: To (1) understand the role of antibiotic-associated adverse events (ABX-AEs) on antibiotic decision-making, (2) understand clinician preferences for ABX-AE feedback, and (3) identify ABX-AEs of greatest clinical concern | ||
| 520 | |a Design: Focus groups | ||
| 520 | |a Setting: Academic medical center | ||
| 520 | |a Participants: Medical and surgical house staff, attending physicians, and advanced practice practitioners | ||
| 520 | |a Methods: Focus groups were conducted from May 2022 to December 2022. Participants discussed the role of ABX-AEs in antibiotic decision-making and feedback preferences and evaluated the prespecified categorization of ABX-AEs based on degree of clinical concern. Thematic analysis was conducted using inductive coding | ||
| 520 | |a Results: Four focus groups were conducted (n = 15). Six themes were identified. (1) ABX-AE risks during initial prescribing influence the antibiotic prescribed rather than the decision of whether to prescribe. (2) The occurrence of an ABX-AE leads to reassessment of the clinical indication for antibiotic therapy. (3) The impact of an ABX-AE on other management decisions is as important as the direct harm of the ABX-AE. (4) ABX-AEs may be overlooked because of limited feedback regarding the occurrence of ABX-AEs. (5) Clinicians are receptive to feedback regarding ABX-AEs but are concerned about it being punitive. (6) Feedback must be curated to prevent clinicians from being overwhelmed with data. Clinicians generally agreed with the prespecified categorizations of ABX-AEs by degree of clinical concern | ||
| 520 | |a Conclusions: The themes identified and assessment of ABX-AEs of greatest clinical concern may inform antibiotic stewardship initiatives that incorporate reporting of ABX-AEs as a strategy to reduce unnecessary antibiotic use | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Helsel, Taylor N |e verfasserin |4 aut | |
| 700 | 1 | |a Jones, George F |e verfasserin |4 aut | |
| 700 | 1 | |a Virk, Zunaira |e verfasserin |4 aut | |
| 700 | 1 | |a Salinas, Alejandra |e verfasserin |4 aut | |
| 700 | 1 | |a Grieb, Suzanne M |e verfasserin |4 aut | |
| 700 | 1 | |a Klein, Eili Y |e verfasserin |4 aut | |
| 700 | 1 | |a Tamma, Pranita D |e verfasserin |4 aut | |
| 700 | 1 | |a Cosgrove, Sara E |e verfasserin |4 aut | |
| 700 | 0 | |a Centers for Disease Control and Prevention’s Prevention Epicenters Program |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Antimicrobial stewardship & healthcare epidemiology : ASHE |d 2021 |g 4(2024), 1 vom: 01., Seite e13 |w (DE-627)NLM331461579 |x 2732-494X |7 nnns |
| 773 | 1 | 8 | |g volume:4 |g year:2024 |g number:1 |g day:01 |g pages:e13 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1017/ash.2024.2 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 4 |j 2024 |e 1 |b 01 |h e13 | ||